A detailed history of Advisor Group Holdings, Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,125 shares of OCUL stock, worth $7,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,125
Previous 1,125 -0.0%
Holding current value
$7,695
Previous $5,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$2.08 - $4.52 $728 - $1,581
-350 Reduced 23.73%
1,125 $5,000
Q3 2023

Nov 13, 2023

SELL
$3.14 - $5.04 $7,966 - $12,786
-2,537 Reduced 63.24%
1,475 $4,000
Q2 2023

Aug 10, 2023

SELL
$4.6 - $7.64 $4,347 - $7,219
-945 Reduced 19.06%
4,012 $20,000
Q1 2023

May 12, 2023

BUY
$2.79 - $6.27 $647 - $1,454
232 Added 4.91%
4,957 $26,000
Q4 2022

Feb 10, 2023

SELL
$2.61 - $4.41 $261 - $441
-100 Reduced 2.07%
4,725 $13,000
Q3 2022

Nov 14, 2022

BUY
$4.09 - $6.5 $4,499 - $7,150
1,100 Added 29.53%
4,825 $20,000
Q1 2022

May 04, 2022

SELL
$4.83 - $7.35 $4,110 - $6,254
-851 Reduced 18.6%
3,725 $18,000
Q3 2021

Nov 05, 2021

BUY
$9.7 - $14.34 $11,640 - $17,208
1,200 Added 35.55%
4,576 $46,000
Q2 2021

Aug 02, 2021

BUY
$13.43 - $19.16 $11,751 - $16,765
875 Added 34.99%
3,376 $48,000
Q1 2021

May 13, 2021

BUY
$15.82 - $22.11 $30,058 - $42,009
1,900 Added 316.14%
2,501 $41,000
Q4 2020

Feb 10, 2021

SELL
$7.91 - $22.95 $4,342 - $12,599
-549 Reduced 47.74%
601 $12,000
Q3 2020

Nov 12, 2020

BUY
$7.36 - $9.87 $1,840 - $2,467
250 Added 27.78%
1,150 $9,000
Q2 2020

Aug 14, 2020

BUY
$4.67 - $8.95 $4,203 - $8,054
900 New
900 $7,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.